Québec, Québec
Canada G1J 1Z4
Dernières nouvelles
Information non disponible
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
Article de revueLancet, 400 (10347), 2022.
Evaluation of Intensive vs Standard Blood Pressure Reduction and Association With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis
Article de revueJAMA Netw Open, 4 (11), 2021.
Predictors of neurologists confirming or overturning emergency physicians' diagnosis of TIA or stroke
Article de revueCJEM, 23 (6), 2021.
Sex Differences in Diagnosis and Diagnostic Revision of Suspected Minor Cerebral Ischemic Events
Article de revueNeurology, 96 (5), 2021.
Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study
Article de revueBMJ, 372 , 2021.
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
Article de revueLancet, 395 (10227), 2020.
Haemorrhagic Transformation of a MELAS Stroke-Like Lesion
Article de revueCan J Neurol Sci, 47 (1), 2020.
Rate and Prognosis of Brain Ischemia in Patients With Lower-Risk Transient or Persistent Minor Neurologic Events
Article de revueJAMA Neurol, 76 (12), 2019.
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial
Article de revueJ Stroke Cerebrovasc Dis, 27 (6), 2018.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Article de revueN Engl J Med, 378 (23), 2018.
Projets terminés récemment
- ESCAPE-NA1 - Phase III, randomized, multicentre clinical trial, du 2017-04-01 au 2021-03-31
- TEMPO 2 - A randomized controlled trial of TNK-Tpa versus standard of care for minor ischemic stroke with proven occlusion., du 2016-05-20 au 2021-12-25